Ally Bridge Group »

Tyra Biosciences shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Tyra Biosciences (TYRA) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Tyra Biosciences

Jun 302024Jul 14Jul 28Aug 11Aug 25Sep 8Sep 224.5M5M5.5M6M6.5M266k268k270k
Value ($)Share countHistorical TYRA position of Ally Bridge Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Tyra Biosciences held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tyra Biosciences by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.3M 270k 23.51
2024-06-30 $4.2M 265k 15.99

More positions owned by Ally Bridge Group

Insmed Com Par $.01 (INSM)
Tarsus Pharmaceuticals (TARS)
Merus N V (MRUS)
Cg Oncology (CGON)
Blueprint Medicines (BPMC)
Sarepta Therapeutics (SRPT)
Xenon Pharmaceuticals (XENE)
Longboard Pharmaceuticals In
Jasper Therapeutics Com New (JSPR)
Revolution Medicines (RVMD)
Springworks Therapeutics (SWTX)
Tyra Biosciences (TYRA)
Eliem Therapeutics (CLYM)
Geron Corporation (GERN)
Enliven Therapeutics (ELVN)

View all positions for Ally Bridge Group

Top funds holding Tyra Biosciences

RA Capital Management
Canaan Partners XI
Alta Partners Management Company
Nextech Invest
BVF
FMR
Boxer Capital Management
TCG Crossover Management
Henderson Group
BlackRock
OrbiMed Advisors
Vanguard Group
Farallon Capital Management
5AM Venture Management
Geode Capital Management

View all funds holding Tyra Biosciences